Locally advanced/inflammatory breast cancers treated with intensive epirubicin-based neoadjuvant chemotherapy: are there molecular markers in the primary tumour that predict for 5-year clinical outcome?
Titel:
Locally advanced/inflammatory breast cancers treated with intensive epirubicin-based neoadjuvant chemotherapy: are there molecular markers in the primary tumour that predict for 5-year clinical outcome?
Auteur:
Bonnefoi, H. Diebold-Berger, S. Therasse, P. Hamilton, A. van de Vijver, M. MacGrogan, G. Shepherd, L. Amaral, N. Duval, C. Drijkoningen, R. Larsimont, D. Piccart, M.